Jayanthi Srinivasiah, M.D., Chair
Breast Working Group for Augusta University MB-NCORP
Board Certified in medical oncology and hematology, Jayanthi Srinivasiah (Dr. Jay), M.D. serves as the Principal Investigator for the DeKalb Medical research program and has been a leader in the development of the cancer program. In her many years with DeKalb Medical, she has successfully managed over 25 clinical trials. She was awarded the Silver Award from the National Cancer Institute’s Community Clinical Oncology Program (CCOP) for the number of patients enrolled in clinical trials.
Dr. Jay completed her medical degree at Bangalore Medical College in Bangalore, India,
and residencies at Louis A. Weiss Memorial Hospital in Chicago, IL and the University
of Iowa in Iowa City, IA. She completed a fellowship at Emory University in Atlanta,
GA. Dr. Jay’s areas of special interest include: breast cancer, genetics, colon cancer,
lung cancer, and benign hematology. Dr. Jay recently returned from India where she
taught a three-day course in genetics and genomics at Kolar Medical College. The thirty
participants at the medical school included both post-graduate students and professors.
Dr. Jay is a member of the Medical Association of Georgia, the American Society of Clinical Oncology, and the DeKalb County Medical Society. Dr. Jay chairs the Cancer Committee at DeKalb Medical, which includes the chairing of the Clinical Trials and Genetics Committees. She functions as an investigator with the Center for Oncology Research and Education (CORE). Dr. Jay currently serves on the GCS Board of Directors.
DeKalb Medical Cancer Center’s research department is staffed by five oncology certified nurses: Cathy Comer (Manager), Lynn Dixon, Rachel Coleman, Dena Horton and Jodean LaPoint. Ruthie Sweat is the Data Manager and Regulatory Specialist for the department.
Our mission is to accelerate cancer research by continuously strengthening the cancer program at DeKalb Medical Center. By teaming with other cancer center personnel (diagnostic technicians, navigators, specialized physicians, surgeons, genetics, infusion center nurses, radiation oncologists, and chaplains) our goal is to participate in the multi-disciplinary assessment of each patient’s treatment planning. Patients that participate in clinical trials are monitored closely and may have better outcomes. In an effort to identify the best available treatment for each patient, research opportunities are included in a multi-disciplinary approach. We strive to maintain a broad menu of trials including prevention trials to offer our patients.